Sign in

CIK 0001635077 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Aclarion, Inc.

Sign in to watch
Ticker
ACON
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473324725
Phone
833 275 2266
Business address
8181 ARISTA PLACE, STE 100, BROOMFIELD, CO, 80021
Former names
Nocimed, Inc.

Securities

  • ACON Common Stock Nasdaq
  • ACONW Warrant Nasdaq
  1. 4 Open-market buy Director bought 5,857 shares at $2.73 ($15,990)
  2. 4 Open-market buy CFO bought 10,000 shares at $2.45 ($24,500)
  3. 4 Open-market buy Director bought 21,122 shares at $2.37 ($50,059)
  4. 4 Open-market buy Director bought 2,150 shares at $2.34 ($5,031)
  5. 4 Open-market buy Director bought 7,500 shares at $2.40 ($18,000)
  6. 4 Open-market buy Chief Executive Officer bought 5,234 shares at $2.31 ($12,091)
  7. 4 Grant or award Chief Strategy Officer acquired 55,000 shares (grant or award)
  8. 4 Grant or award Director acquired 20,000 shares (grant or award)
  9. 4 Grant or award Director acquired 20,000 shares (grant or award)
  10. 4 Grant or award Chief Financial Officer acquired 50,000 shares (grant or award)
  11. 4 Grant or award Chief Executive Officer acquired 100,000 shares (grant or award)
  12. 4 Grant or award Director acquired 20,000 shares (grant or award)
  13. 4 Grant or award Executive Chairman acquired 100,000 shares (grant or award)
  14. 4 Grant or award Director acquired 20,000 shares (grant or award)
  15. 4 Grant or award Director acquired 20,000 shares (grant or award)
  16. 4 Open-market buy Director bought 5,664 shares at $3.18 ($18,012)
  17. 4 Open-market buy Director bought 2,500 shares at $3.10 ($7,750)
  18. 4 Open-market buy Chief Executive Officer bought 6,289 shares at $3.18 ($19,999)
  19. 4 Open-market buy Director bought 1,562 shares at $3.30 ($5,155)
  20. 4 Open-market buy Chief Executive Officer bought 10 shares at $6.20 ($62)

Page 1 of 3 · 54 filings